Abivax Cash Flow Statement (2024-2026) | ABVX

Cash Flow Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -46.57M-41.75M-60.65M-42.03M-55.09M-54.80M-179.28M-88.65M-56.48M
Share-based Compensation (Quarter) 6.25M6.10M4.77M4.76M4.93M7.17M13.42M15.02M26.47M
Cash from Discontinued Operations (Quarter) -35.00M-59.14M
Gains from Investment Securities (Quarter) -0.42M1.95M0.29M-0.29M1.14M1.75M73.95M
Cash from Operations (Quarter) -37.76M-54.30M-38.86M-35.84M-35.00M-37.74M-83.33M-27.00M
Depreciation, Depletion & Amortization
Amortization (Quarter) 104.41M122.08M116.71M151.70M111.73M
Depreciation & Amortization (CF) (Quarter) 0.23M0.39M0.27M0.30M0.29M0.28M0.32M0.32M0.43M
Change in Working Capital
Change in Receivables (Quarter) -0.74M5.06M-2.92M3.45M-2.27M5.03M-5.36M10.88M-4.08M
Change in Account Payables (Quarter) 5.65M-24.21M15.01M0.18M13.42M1.11M-32.73M9.37M-9.42M
Investing Activities
Change in Net Loans (Quarter) 24.81M53.70M
Capital Expenditures (Quarter) -0.01M-0.24M-0.34M1.27M-0.05M-0.02M0.01M0.23M-0.06M
Change in Acquisitions & Divestments (Quarter) 1.77M2.44M
Cash from Investing Activities (Quarter) 2.07M12.45M1.92M0.63M1.14M0.21M3.83M-14.84M0.58M
Financing Activities
Other financing activities (Quarter) 0.00M0.26M0.00M0.26M0.06M0.01M
Debt Issuance and Repayment
Short-Term Debt repayments (Quarter) -0.16M-0.14M-0.14M-0.24M-0.26M-0.38M-0.48M
Change in Capital Stock
Shares Issued (Quarter) 0.00M0.03M
Misc.
Cash from Financing Activities (Quarter) 23.03M20.59M-6.91M-6.23M-8.24M-9.92M705.48M-46.05M0.09M
Exchange Rate Effect (Quarter) 1.43M0.49M-2.13M2.75M-0.74M-1.23M-8.36M-1.58M8.68M
Change in Cash (Quarter) -11.23M-20.77M-45.98M-38.69M-42.75M-48.25M618.14M-84.95M-45.97M
Beginning Cash Balance (Quarter) -6.44M-14.75M
Free Cash Flow (Quarter) -37.74M-54.06M-38.52M-37.11M-34.96M-37.72M-83.34M-27.23M0.06M
Net Cash Flow (Quarter) -12.66M-21.26M-43.85M-41.44M-42.11M-47.45M625.98M-87.89M0.66M